Julia P. M.
- Country
- France
- Department
- Medical oncology
Research Overview
- Phase 3 Randomized Study of Perioperative Enfortumab Vedotin and Pembrolizumab Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
- Phase II Evaluation of De-escalated Therapy with Etoposide, Cisplatin, and Carboplatin in Stage IIa/IIb Seminoma Less Than 3 cm
- Phase III Randomized Trial of Avelumab, Cetuximab, and Radiotherapy Versus Standard Care in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Data & Insights
Has run more than one trial at 19 of 130 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating advanced urothelial carcinoma and muscle invasive bladder cancer, exploring innovative therapeutic approaches in urological malignancies.
- Advanced Bladder Cancer Management
- Platinum-based Treatment Strategies
- Immunotherapy Applications
Their work encompasses both perioperative care and maintenance therapy approaches in urological cancers.
Head and Neck Oncology
Focused on treating squamous cell carcinoma of the head and neck, particularly in advanced stages affecting the oral cavity, oropharynx, hypopharynx, and larynx.
- Combined Immunotherapy Approaches
- Radiotherapy Integration
- Advanced Stage Disease Treatment
The investigator explores innovative combinations of targeted therapies with conventional treatments.
Testicular Cancer
Expertise in treating stage IIa/IIb seminoma, with particular focus on therapeutic optimization and treatment de-escalation strategies.
- De-escalation Protocols
- Biomarker Evaluation
- Combined Modality Treatment
Their research includes evaluation of novel treatment approaches and response monitoring using advanced imaging techniques.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.